ArticleInternational journal of oncology2023

CUDC‑101 is a potential target inhibitor for the EGFR‑overexpression bladder cancer cells.

Zhenxing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.